methylprednisolone hemisuccinate has been researched along with Liver Failure, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, D; Mojtahed, A; Yeh, AM | 1 |
| Aishima, S; Enjoji, M; Fukui, Y; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Takayanagi, R | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Liver Failure, Acute
| Article | Year |
|---|---|
Acute liver failure and aplastic anemia in an 11-year-old girl.
Topics: Acetylcysteine; Anemia, Aplastic; Antilymphocyte Serum; Bilirubin; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Failure, Acute; Methylprednisolone Hemisuccinate; Platelet Transfusion; Prednisone; Transaminases; Treatment Outcome; Vitamin K | 2011 |
Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Injections, Intravenous; Interferon-gamma; Lipopolysaccharides; Liver Failure, Acute; Male; Methylprednisolone Hemisuccinate; Portal Vein; Rats; Rats, Wistar; Survival Rate; Tumor Necrosis Factor-alpha | 2007 |